Released: February 27, 2015

Defense Health Program
Department of Defense Peer Reviewed Cancer Research Program
Fiscal Year 2015 Appropriation Announcement

The Fiscal Year 2015 (FY15) Defense Appropriations Act provides $50 million to the Department of Defense Peer Reviewed Cancer Research Program (PRCRP). The funding is provided to support select medical research projects of clear scientific merit and relevance to military health.

Research support is restricted to the following Congressionally directed FY15 Topic Areas:

  • Colorectal cancer
  • Genetic cancer
  • Kidney cancer
  • Listeria vaccine for cancer
  • Liver cancer
  • Melanoma and other skin cancers
  • Mesothelioma
  • Myeloproliferative disorders
  • Neuroblastoma
  • Pancreatic cancer
  • Stomach cancer

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, Research, Development, and Acquisition Directorate manages and executes the Defense Health Program Research, Development, Test, and Evaluation appropriation. The executing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

FY15 PRCRP Program Announcements and General Application Instructions are anticipated to be posted on in March/April 2015 with specified application deadlines. This press release should not be construed as an obligation by the government.

All applications must conform to the final Program Announcement and General Application Instructions that will be available for electronic downloading from the website. The application package containing the required forms for the award mechanism will also be found on A listing of all USAMRMC funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420.

Point of Contact:

CDMRP Public Affairs